Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangxin Biosciences develops and manufactures biochemical drugs, feed additives such as amino acids and nucleotides, and food additive ingredients. The company has received significant funding for expansion and innovation in intelligent biomanufacturing technologies. It operates under the umbrella of Guangdong Guangxin Holdings Group Ltd., a major state-owned enterprise with broad interests in biotechnology.
No clinical trial results are reported as the company's main business centers on industrial biotech production rather than pharmaceutical clinical development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangxin Biosciences.